These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 23609373)
1. Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma. Chen S; Hou JH; Feng XY; Zhang XS; Zhou ZW; Yun JP; Chen YB; Cai MY J Surg Oncol; 2013 Jun; 107(8):799-806. PubMed ID: 23609373 [TBL] [Abstract][Full Text] [Related]
2. Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysis. Bi Y; Meng Y; Wu H; Cui Q; Luo Y; Xue X J Surg Oncol; 2016 Feb; 113(2):144-51. PubMed ID: 26799258 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma. Xi HQ; Zhao P J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057 [TBL] [Abstract][Full Text] [Related]
4. Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma. Zhang Y; Sun B; Zhao X; Liu Z; Wang X; Yao X; Dong X; Chi J J Surg Oncol; 2013 Nov; 108(6):414-9. PubMed ID: 23996537 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer. Horst D; Kriegl L; Engel J; Kirchner T; Jung A Cancer Invest; 2009 Oct; 27(8):844-50. PubMed ID: 19626493 [TBL] [Abstract][Full Text] [Related]
6. Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma--their prognostic significance. Okudela K; Woo T; Mitsui H; Tajiri M; Masuda M; Ohashi K Pathol Int; 2012 Dec; 62(12):792-801. PubMed ID: 23252868 [TBL] [Abstract][Full Text] [Related]
7. The Expression Status and Prognostic Value of Cancer Stem Cell Biomarker CD133 in Cutaneous Squamous Cell Carcinoma. Xu R; Cai MY; Luo RZ; Tian X; Han JD; Chen MK JAMA Dermatol; 2016 Mar; 152(3):305-11. PubMed ID: 26560495 [TBL] [Abstract][Full Text] [Related]
8. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors. Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of stem cell marker CD133 expression in colorectal cancer. Wang BB; Li ZJ; Zhang FF; Hou HT; Yu JK; Li F Histol Histopathol; 2016 Mar; 31(3):299-306. PubMed ID: 26442717 [TBL] [Abstract][Full Text] [Related]
10. Sequential expression of putative stem cell markers in gastric carcinogenesis. Wang T; Ong CW; Shi J; Srivastava S; Yan B; Cheng CL; Yong WP; Chan SL; Yeoh KG; Iacopetta B; Salto-Tellez M Br J Cancer; 2011 Aug; 105(5):658-65. PubMed ID: 21829201 [TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of CD133 expression in gastric carcinoma. Ishigami S; Ueno S; Arigami T; Uchikado Y; Setoyama T; Arima H; Kita Y; Kurahara H; Okumura H; Matsumoto M; Kijima Y; Natsugoe S Anticancer Res; 2010 Jun; 30(6):2453-7. PubMed ID: 20651407 [TBL] [Abstract][Full Text] [Related]
12. CD44 is of functional importance for colorectal cancer stem cells. Du L; Wang H; He L; Zhang J; Ni B; Wang X; Jin H; Cahuzac N; Mehrpour M; Lu Y; Chen Q Clin Cancer Res; 2008 Nov; 14(21):6751-60. PubMed ID: 18980968 [TBL] [Abstract][Full Text] [Related]
13. Aberrant Expression of Markers of Cancer Stem Cells in Gastric Adenocarcinoma and their Relationship to Vasculogenic Mimicry. Zhou L; Yu L; Feng ZZ; Gong XM; Cheng ZN; Yao N; Wang DN; Wu SW Asian Pac J Cancer Prev; 2015; 16(10):4177-83. PubMed ID: 26028069 [TBL] [Abstract][Full Text] [Related]
14. Decreased expression of Beclin 1 correlates with a metastatic phenotypic feature and adverse prognosis of gastric carcinomas. Chen YB; Hou JH; Feng XY; Chen S; Zhou ZW; Zhang XS; Cai MY J Surg Oncol; 2012 May; 105(6):542-7. PubMed ID: 22095667 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of the Stem Cell Markers Epcam and CD133 Expression Of Gallbladder Adenocarcinoma. Jiang S; Pei L; Yang ZL; Liu G Hepatogastroenterology; 2014 May; 61(131):574-9. PubMed ID: 26176038 [TBL] [Abstract][Full Text] [Related]
16. Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma. Yu JW; Zhang P; Wu JG; Wu SH; Li XQ; Wang ST; Lu RQ; Ni XC; Jiang BJ J Exp Clin Cancer Res; 2010 Nov; 29(1):141. PubMed ID: 21054902 [TBL] [Abstract][Full Text] [Related]
17. Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients. Reggiani Bonetti L; Migaldi M; Caredda E; Boninsegna A; Ponz De Leon M; Di Gregorio C; Barresi V; Scannone D; Danese S; Cittadini A; Sgambato A Scand J Gastroenterol; 2012 Oct; 47(10):1211-7. PubMed ID: 22856425 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis. Han Z; Chen Z; Zheng R; Cheng Z; Gong X; Wang D World J Surg Oncol; 2015 Feb; 13():56. PubMed ID: 25889325 [TBL] [Abstract][Full Text] [Related]
19. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer. Kapucuoğlu N; Bozkurt KK; Başpınar Ş; Koçer M; Eroğlu HE; Akdeniz R; Akçil M Pathol Res Pract; 2015 Oct; 211(10):740-7. PubMed ID: 26298632 [TBL] [Abstract][Full Text] [Related]
20. Expression of cancer stem cell markers and their correlation with pathogenesis in vascular tumors. Lan J; Huang B; Liu R; Ju X; Zhou Y; Jiang J; Liang W; Shen Y; Li F; Pang L Int J Clin Exp Pathol; 2015; 8(10):12621-33. PubMed ID: 26722452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]